11056
S.K. Mandal, S.C. Roy / Tetrahedron 64 (2008) 11050–11057
(15 mL), brine (15 mL) and finally dried (Na2SO4). After evaporation
of the solvent the residual mass was chromatographed over silica
gel (5% ethyl acetate in light petroleum) to afford 17 (1.35 g, 96%) as
a colourless oil. Rf¼0.62 (5% ethyl acetate in light petroleum); IR
(KBr): nmax 1735, 1467, 1290, 840 cmꢃ1; 1H NMR (300 MHz, CDCl3):
3.27. Synthesis of hydrangenol (1) from 18
A solution of 18 (537 mg, 1.5 mmol) and 4-(tert-butyldime-
thylsilyloxy)-benzaldehyde 20 (354 mg, 1.5 mmol) in THF (15 mL)
was reacted in the presence of Cp2TiCl in THF followed by acidic
work-up as described for the preparation of 13 to give hydrangenol
(1) as colourless needles (196 mg, 51%).
d
0.22 (s, 6H), 0.97 (s, 9H), 2.28 (s, 3H), 3.87 (s, 3H), 6.67 (d, J¼8.2 Hz,
1H), 6.78 (d, J¼7.5 Hz, 1H), 7.13 (dd, J¼7.5, 8.2 Hz, 1H); 13C NMR
(75 MHz, CDCl3):
126.6, 130.0, 136.7, 152.5, 169.0; HRMS (ESI) calcd for C15H25O3Si
d
ꢃ4.3 (2C), 18.1, 19.4, 25.6 (3C), 52.0, 116.4, 122.7,
3.28. Thunberginol G dimethyl ether (19)
281.1567 [MþH]þ, found 281.1552.
A
solution of 18 (537 mg, 1.5 mmol) and 3,4-dimethoxy-
benzaldehyde 23 (250 mg, 1.5 mmol) in THF (15 mL) was reacted in
the presence of Cp2TiCl in THF followed by acidic work-up as
described for the preparation of 13 to give compound 19 as a col-
ourless needles (238 mg, 53%). Mp 105–107 ꢁC. Rf¼0.27 (25% ethyl
3.24. Methyl 2-(tert-butyldimethylsilyloxy)-6-
(bromomethyl)-benzoate (18)
N-Bromosuccinamide (356 mg, 2 mmol) was added to a solution
of 17 (560 mg, 2 mmol) in CCl4 (10 ml) and heated to reflux under
visible light. A catalytic amount of AIBN (4 mg) was added and the
reflux continued for 2 h. After cooling, the solids were filtered off
and the filtrate concentrated under reduced pressure. It was diluted
with diethyl ether (20 mL) and washed with water (10 mL), brine
(10 mL) and finally dried (Na2SO4). After removal of the solvent in
vacuo the residue obtained was purified by column chromatogra-
phy over silica gel (5% ethyl acetate in light petroleum) to obtain the
benzyl bromide 18 (688 mg, 96%) as a colourless oil. Rf¼0.60 (5%
ethyl acetate in light petroleum); IR (KBr): nmax 1728, 1465, 1296,
acetate in light petroleum); IR (KBr): nmax 1670, 1616, 1232 cmꢃ1
;
1H NMR (300 MHz, CDCl3):
d
2.99 (dd, J¼3.1, 16.5 Hz, 1H), 3.22 (dd,
J¼12.2, 16.5 Hz, 1H), 3.78 (s, 3H), 3.79 (s, 3H), 5.41 (dd, J¼3.1,
12.2 Hz,1H), 6.63 (d, J¼7.3 Hz,1H), 6.76–6.89 (m, 4H), 6.84–6.89 (m,
2H), 7.33 (dd, J¼7.9, 8.0 Hz, 1H), 10.90 (s, 1H); 13C NMR (75 MHz,
CDCl3):
d 35.1, 56.0 (2C), 80.9, 108.4, 109.4, 111.0, 116.3, 118.0, 118.8,
130.4, 136.4, 139.4, 149.2, 149.5, 162.2, 169.9; HRMS (ESI) calcd for
C17H17O5 301.1071 [MþH]þ, found 301.1077.
3.29. Thunberginol G (4)
842 cmꢃ1 1H NMR (300 MHz, CDCl3):
; d 0.22 (s, 6H), 0.97 (s, 9H),
Compound 19 (150 mg, 0.5 mmol) was treated with BBr3 (1 M,
2 mL) in CH2Cl2 (2 mL) following the same procedure described for
1 to give thunberginol (4) (117 mg, 86%) as a white solid. Mp 176–
178 ꢁC. Rf¼0.21 (30% ethyl acetate in light petroleum); IR (KBr): nmax
3.90 (s, 3H), 4.49 (s, 2H), 6.79 (d, J¼7.9 Hz, 1H), 6.98 (d, J¼7.6 Hz,
1H), 7.22 (dd, J¼7.6, 7.9 Hz, 1H); 13C NMR (75 MHz, CDCl3):
d
ꢃ4.3
(2C), 18.1, 25.6 (3C), 30.3, 52.3, 119.6, 122.7, 126.0, 130.8, 136.9, 153.2,
167.8; HRMS (ESI) calcd for C15H23O3BrSiNa 381.0497 [MþNa]þ,
found 381.0529.
3303, 1658, 1614, 1203 cmꢃ1; 1H NMR (300 MHz, DMSO-d6):
d 3.12
(dd, J¼2.9, 16.5 Hz, 1H), 3.33 (dd, J¼11.8, 16.5 Hz, 1H), 5.59 (dd,
J¼2.9, 11.8 Hz, 1H), 6.77–6.91 (m, 5H), 7.51 (dd, J¼7.8, 7.9 Hz, 1H),
9.07 (s, 1H), 9.10 (s, 1H), 10.95 (s, 1H); 13C NMR (75 MHz, DMSO-d6):
3.25. Phyllodulcin (2)
d
33.1, 80.0, 108.0, 113.7, 114.9 (2C), 117.3, 117.9, 128.5, 135.8, 140.1,
A solution of 18 (537 mg, 1.5 mmol) and 3-(tert-butyldime-
thylsilyloxy)-4-methoxybenzaldehyde 21 (400 mg, 1.5 mmol) in
THF (15 mL) was reacted in the presence of Cp2TiCl in THF followed
by acidic work-up as described for the preparation of 13 to give
phyllodulcin (2) as a colourless needles (245 mg, 57%). Mp 127–
129 ꢁC (lit. 128–130 ꢁC). Rf¼0.16 (20% ethyl acetate in light petro-
144.7, 145.3, 160.4, 168.9; HRMS (ESI) calcd for C15H12O5Na:
295.0583 [MþNa]þ, found 295.0584.
Acknowledgements
We thank DST, New Delhi for financial support. S.K.M. thanks
CSIR, New Delhi for awarding the research fellowship.
leum); IR (KBr): nmax 3352, 1670, 1618, 1230 cmꢃ1
;
1H NMR
(300 MHz, DMSO-d6):
d
3.16 (dd, J¼3.2, 16.5 Hz, 1H), 3.37 (dd,
J¼11.6, 16.5 Hz, 1H), 3.78 (s, 3H), 5.66 (dd, J¼3.2, 11.6 Hz, 1H), 6.87–
Supplementary data
6.97 (m, 5H), 7.53 (dd, J¼7.9, 8.0 Hz, 1H), 9.12 (s, 1H), 10.92 (s, 1H);
13C NMR (75 MHz, DMSO-d6):
d 33.5, 55.6, 80.1, 108.4, 111.9, 113.9,
Supplementary data associated with this article can be found in
115.4, 117.5, 118.4, 130.7, 136.3, 140.4, 146.4, 147.9, 160.9, 169.2;
HRMS (ESI) calcd for C16H14O5Na: 309.0739 [MþNa]þ, found
309.0730.
References and notes
1. (a) Nozawa, K.; Yamada, M.; Tsuda, Y.; Kawai, K.; Nakajima, S. Chem. Pharm. Bull.
1981, 29, 2689; (b) ShimoJima, Y.; Shirai, T.; Baba, T.; Hayashi, H. J. Med. Chem.
1885, 28, 3; (c) Fusetani, N.; Sugawar, T.; Matsunaga, S.; Hirota, H. J. Org. Chem.
1991, 56, 4971; (d) Yoshikawa, M.; Uchida, E.; Chatani, N.; Kobayashi, H.; Naitoh,
Y.; Okuno, Y.; Matsuda, H.; Yamahara, J.; Murakami, N. Chem. Pharm. Bull. 1992,
40, 3352; (e) Yoshikawa, M.; Ueda, T.; Shimoda, H.; Murakami, T.; Yamahara, J.;
Matsuda, H. Chem. Pharm. Bull. 1999, 47, 383; (f) Umehara, K.; Matsumoto, M.;
Nakamura, M.; Miyase, T.; Kuroyanagi, M.; Noguchi, H. Chem. Pharm. Bull. 2000,
48, 566; (g) Kongsaeree, P.; Prabpai, S.; Sriubolmas, N.; Vongvein, C.; Wiyak-
rutta, S. J. Nat. Prod. 2003, 66, 709; (h) Kokubun, T.; Veitch, N. C.; Bridge, P. D.;
Simmonds, M. S. J. Phytochemistry 2003, 62, 779; (i) Zidorn, C.; Lohwasser, U.;
Pschorr, S.; Salvenmoser, D.; Ongania, K.-H.; Ellmerer, E. P.; Bo¨rner, A.; Stuppner,
H. Phytochemistry 2005, 66, 1691; (j) Jiao, P.; Gloer, J. B.; Campbell, J.; Shearer, C.
A. J. Nat. Prod. 2006, 69, 612.
3.26. Macrophyllol (3)
A solution of 18 (537 mg, 1.5 mmol) and 3,4,5-trimethoxy-
benzaldehyde 22 (294 mg, 1.5 mmol) in THF (15 mL) was reacted in
the presence of Cp2TiCl in THF followed by acidic work-up as de-
scribed for the preparation of 13 to give macrophyllol (3) as a col-
ourless needles (272 mg, 55%). Mp 149–151 ꢁC (lit.2c 151–153 ꢁC).
Rf¼0.22 (25% ethyl acetate in light petroleum); IR (KBr): nmax 3408,
1664,1620,1230 cmꢃ1; 1H NMR (300 MHz, CDCl3):
d
3.12 (dd, J¼2.8,
16.5 Hz, 1H), 3.32 (dd, J¼12.1, 16.5 Hz, 1H), 3.86 (s, 3H), 3.88 (s, 6H),
5.52 (dd, J¼2.8, 12.1 Hz, 1H), 6.67 (s, 2H), 6.75 (d, J¼7.3 Hz, 1H), 6.93
(d, J¼8.4 Hz, 1H), 7.45 (dd, J¼7.8, 8.0 Hz, 1H), 10.96 (s, 1H); 13C NMR
2. (a) Asahina, Y.; Asano, J. Chem. Ber. 1929, 62B, 171; (b) Asahina, Y.; Asano, J.
Chem. Ber. 1930, 63B, 429; (c) Hashimoto, T.; Tori, M.; Asakawa, Y. Phytochem-
istry 1987, 26, 3323; (d) Yoshikawa, M.; Matsuda, H.; Shimoda, H.; Shimada, H.;
Harada, E.; Naitoh, Y.; Miki, A.; Yamahara, J.; Murakami, N. Chem. Pharm. Bull.
1996, 44, 1440.
(75 MHz, CDCl3): d 35.5, 56.4 (2C), 61.0, 81.1, 103.4 (2C), 108.5, 116.6,
118.1, 120.3, 133.7, 136.6, 139.3, 153.6 (2C), 162.5, 169.8; HRMS (ESI)
calcd for C18H18O6Na 353.1001 [MþNa]þ, found 353.1014.
3. Matsuda, H.; Shimoda, H.; Yoshikawa, M. Bioorg. Med. Chem. 1999, 7, 1445.